Gizmodo
•
83% Informative
136.8 million Americans are eligible to take semaglutide, the active ingredient in two popular GLP-1 drugs.
About 30 million would benefit from taking it to manage diabetes or reduce risk of cardiovascular disease.
Many insurers, public and private, also do not provide coverage for these drugs at least partly due to high prices.
VR Score
86
Informative language
87
Neutral language
43
Article tone
informal
Language
English
Language complexity
64
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links